The high costs of drug development mean that most early investors no longer own big stakes by the time a medicine finally gets to market.
FORBES: End Of An Era: The Last Herper-Langreth Biotech Story
Almost all the cost of a drug is in the development and the complex hardware required to concoct the chemicals that become the medicine.
FORBES: Gouging The Drug Companies
应用推荐
模块上移
模块下移
不移动